These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 15730728)
1. [New recognition of a role of dyslipidemia and lipid-lowering treatment in pathogenesis of renal disease]. Li XW; Li H Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):881-2. PubMed ID: 15730728 [No Abstract] [Full Text] [Related]
2. Hyperlipidemia and its management in renal disease. Massy ZA; Kasiske BL Curr Opin Nephrol Hypertens; 1996 Mar; 5(2):141-6. PubMed ID: 8744535 [TBL] [Abstract][Full Text] [Related]
3. The pharmacological treatment of dyslipidemia. Dujovne CA; Harris WS Annu Rev Pharmacol Toxicol; 1989; 29():265-88. PubMed ID: 2658772 [No Abstract] [Full Text] [Related]
4. [Effect of lipid-lowering by tonifying kidney]. Dong H Zhong Xi Yi Jie He Za Zhi; 1991 Jan; 11(1):25-7. PubMed ID: 2054888 [No Abstract] [Full Text] [Related]
5. [Treatments for dyslipidemia associated with kidney disease]. Hirano T; Yoshino G Nihon Rinsho; 2001 Mar; 59 Suppl 3():748-52. PubMed ID: 11347167 [No Abstract] [Full Text] [Related]
6. One great leap for lipid lowering drugs. Cardiovasc J S Afr; 2002; 13(5):265-6. PubMed ID: 12557874 [No Abstract] [Full Text] [Related]
7. Niacin as a component of combination therapy for dyslipidemia. Miller M Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785 [TBL] [Abstract][Full Text] [Related]
12. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond. Margaritis M; Antoniades C Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521 [No Abstract] [Full Text] [Related]
13. Assessment and management of vascular disease risk in patients with chronic kidney disease. Brown WV; Bakris G; Lerma E; Chertow G J Clin Lipidol; 2011; 5(4):251-60. PubMed ID: 21784369 [No Abstract] [Full Text] [Related]
14. Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine? Alfonsi JE; Hegele RA; Gryn SE Curr Atheroscler Rep; 2016 May; 18(5):24. PubMed ID: 26993470 [TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine. Chen J; Zhao H; Yang Y; Liu B; Ni J; Wang W J Ethnopharmacol; 2011 Apr; 134(3):919-30. PubMed ID: 21316437 [TBL] [Abstract][Full Text] [Related]
16. Adherence to lipid-lowering agents. Ege MR; Yucel O; Acikgoz S Int J Clin Pract; 2011 Dec; 65(12):1321. PubMed ID: 22093541 [No Abstract] [Full Text] [Related]
17. [Lipid-lowering therapy--from the '80s to the '90s. International symposium, Berlin, 19 September 1992]. Internist (Berl); 1993 Feb; 34(2 Suppl):1-15. PubMed ID: 7591606 [No Abstract] [Full Text] [Related]
18. [Current developments in lipid-lowering treatments]. Krempf M Ann Endocrinol (Paris); 2005 Feb; 66(1):39-40. PubMed ID: 15798592 [No Abstract] [Full Text] [Related]
19. Getting the skinny on lipid-lowering drugs. Kuncl N; Nelson KM Nursing; 2000 Jul; 30(7):52-3. PubMed ID: 10983101 [No Abstract] [Full Text] [Related]